These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19657726)

  • 1. Decreased p21 expression in HPV-18 positive cervical carcinomas.
    Huang LW; Seow KM; Lee CC; Lin YH; Pan HS; Chen HJ
    Pathol Oncol Res; 2010 Mar; 16(1):81-6. PubMed ID: 19657726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
    Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
    Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of key cell cycle markers in squamous cell carcinoma of the cervix positive in human papillomavirus: a comparative study between Chinese and Australian populations].
    Liu JH; Huang H; Huang X; Zeng MS; Li W
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(5):312-6. PubMed ID: 16677523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The site of infection and ethnicity of the patient influence the biological pathways to HPV-induced mucosal cancer.
    Li W; Thompson CH; Cossart YE; O'Brien CJ; Liu J; Scolyer RA; Carter JR; Dalrymple C; Rose BR
    Mod Pathol; 2004 Sep; 17(9):1031-7. PubMed ID: 15143339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
    Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
    Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
    Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
    Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53 codon 72 and p21 codon 31 polymorphisms and susceptibility to cervical adenocarcinoma in Korean women.
    Roh JW; Kim BK; Lee CH; Kim J; Chung HH; Kim JW; Park NH; Song YS; Park SY; Kang SB
    Oncol Res; 2010; 18(9):453-9. PubMed ID: 20524403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
    Helland A; Karlsen F; Due EU; Holm R; Kristensen G; Børresen-Dale Al
    Br J Cancer; 1998 Jul; 78(1):69-72. PubMed ID: 9662253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placenta-Specific Protein 1 Expression in Human Papillomavirus 16/18-Positive Cervical Cancers Is Associated With Tumor Histology.
    Devor EJ; Reyes HD; Gonzalez-Bosquet J; Warrier A; Kenzie SA; Ibik NV; Miller MD; Schickling BM; Goodheart MJ; Thiel KW; Leslie KK
    Int J Gynecol Cancer; 2017 May; 27(4):784-790. PubMed ID: 28375929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of CDK inhibitors and p53 in HPV-negative endocervical adenocarcinoma.
    Omori M; Hashi A; Kondo T; Katoh R; Hirata S
    Int J Gynecol Pathol; 2015 Mar; 34(2):196-203. PubMed ID: 25675191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
    Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
    Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia.
    Jancar N; Kocjan BJ; Poljak M; Lunar MM; Bokal EV
    Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):184-8. PubMed ID: 19477061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
    Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.
    Shin MK; Balsitis S; Brake T; Lambert PF
    Cancer Res; 2009 Jul; 69(14):5656-63. PubMed ID: 19584294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of cyclin D1, p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of cervical neoplasia.
    Portari EA; Russomano FB; de Camargo MJ; Machado Gayer CR; da Rocha Guillobel HC; Santos-Rebouças CB; Brito Macedo JM
    Int J Gynecol Pathol; 2013 Sep; 32(5):501-8. PubMed ID: 23896712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18.
    Saidu NEB; Filić V; Thomas M; Sarabia-Vega V; Đukić A; Miljković F; Banks L; Tomaić V
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer.
    Geraets D; Alemany L; Guimera N; de Sanjose S; de Koning M; Molijn A; Jenkins D; Bosch X; Quint W;
    J Pathol; 2012 Dec; 228(4):534-43. PubMed ID: 22711526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPV genotypes co-infections associated with cervical carcinoma: Special focus on phylogenetically related and non-vaccine targeted genotypes.
    Senapati R; Nayak B; Kar SK; Dwibedi B
    PLoS One; 2017; 12(11):e0187844. PubMed ID: 29161285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.